|
1
|
Marshall DC, Salciccioli JD, Shea BS and
Akuthota P: Trends in mortality from idiopathic pulmonary fibrosis
in the European Union: An observational study of the WHO mortality
database from 2001–2013. Eur Respir J. 51(pii): 17016032018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mikamo M, Kitagawa K, Sakai S, Uchida C,
Ohhata T, Nishimoto K, Niida H, Suzuki S, Nakayama KI, Inui N, et
al: Inhibiting skp2 e3 ligase suppresses bleomycin-induced
pulmonary fibrosis. Int J Mol Sci. 19(pii): E4742018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miao C, Xiong Y, Zhang G and Chang J:
MicroRNAs in idiopathic pulmonary fibrosis, new research progress
and their pathophysiological implication. Exp Lung Res. 44:178–190.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Redente EF, Aguilar MA, Black BP, Edelman
BL, Bahadur AN, Humphries SM, Lynch DA, Wollin L and Riches DWH:
Nintedanib reduces pulmonary fibrosis in a model of rheumatoid
arthritis-associated interstitial lung disease. Am J Physiol Lung
Cell Mol Physiol. 314:L998–L1009. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fernández MC, Gonzalez A, Caputo F,
Bottinelli Y, Nastavi P and Zamboni M: Pulmonary fibrosis
associated with anti-neutrophil cytoplasmic antibody positive
vasculitis. Medicina (B Aires). 72:329–331. 2012.(In Spanish).
PubMed/NCBI
|
|
6
|
Stevenson DK, Ostrander CE and Johnson JD:
Effect of erythrocyte destruction on the pulmonary excretion rate
of carbon monoxide in adult male Wistar rats. J Lab Clin Med.
94:649–654. 1979.PubMed/NCBI
|
|
7
|
Yoshinouchi T, Ohtsuki Y, Ueda R, Sato S
and Ueda N: Myofibroblasts and S-100 protein positive cells in
idiopathic pulmonary fibrosis and rheumatoid arthritis-associated
interstitial pneumonia. Eur Respir J. 14:579–584. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sadeghi S, Granton JT, Akhavan P,
Pasarikovski CR, Roos AM, Thenganatt J, Moric J and Johnson SR:
Survival in rheumatoid arthritis-associated pulmonary arterial
hypertension compared with idiopathic pulmonary arterial
hypertension. Respirology. 20:481–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitamura A, Matsuno T, Narita M, Shimokata
K, Yamashita Y and Mori N: Rheumatoid arthritis with diffuse
pulmonary rheumatoid nodules. Pathol Int. 54:798–802. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grumelli S, Corry DB, Song LZ, Song L,
Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE and Kheradmand
F: An immune basis for lung parenchymal destruction in chronic
obstructive pulmonary disease and emphysema. PLoS Med. 1:e82004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taraseviciene-Stewart L, Douglas IS,
Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR and Voelkel NF: Is
alveolar destruction and emphysema in chronic obstructive pulmonary
disease an immune disease? Proc Am Thorac Soc. 3:687–690. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arcangeli G, Cupelli V and Giuliano G:
Effects of silica on human lung fibroblast in culture. Sci Total
Environ. 270:135–139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gomes I, Espendshade B, Varga J and
Ackerman S: Eosinophil-derived IL-1β, TGF-β and bFGF induce lung
fibroblast secretion of the pro-fibrogenic cytokine IL-6: A
potential mechanism for subepithelial fibrosis in asthma. J Allergy
Clin Immunol. 111 (Suppl):S1872003. View Article : Google Scholar
|
|
14
|
An J, Xu R and Musser J: Methods for
isolation of triptolide compounds from tripterygium WilfordII.
Google Patents. 2007.
|
|
15
|
Fan D, He X, Bian Y, Guo Q, Zheng K, Zhao
Y, Lu C, Liu B, Xu X, Zhang G and Lu A: Triptolide modulates TREM-1
signal pathway to inhibit the inflammatory response in rheumatoid
arthritis. Int J Mol Sci. 17:4982016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lei DL, Li MB, Xiong K, Deng XH and Luo
XG: Triptolide inhibits the Aβ deposition and senile plaques
formation in the hippocampus of APP/PS1 double transgenic mice.
Acta Anatomica Sinica. 40:369–373. 2009.
|
|
17
|
Zhang C, Cui GH, Liu F, Wu QL and Chen Y:
Effects of triptolide on cell proliferation and CXCR4 expression in
Burkitt's lymphoma Raji cells in vitro. Chin J Cancer Res.
19:27–31. 2007. View Article : Google Scholar
|
|
18
|
Reno TA, Kim JY and Raz DJ: Triptolide
inhibits lung cancer cell migration, invasion, and metastasis. Ann
Thoracic Surg. 100:1817–1825. 2015. View Article : Google Scholar
|
|
19
|
Yang S, Zhang M, Chen C, Cao Y, Tian Y,
Guo Y, Zhang B, Wang X, Yin L, Zhang Z, et al: Triptolide mitigates
radiation-induced pulmonary fibrosis. Radiat Res. 184:509–517.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Del Rev. 63:610–615. 2011. View Article : Google Scholar
|
|
21
|
Zhang J, Fan G, Zhao H, Wang Z, Li F,
Zhang P, Zhang J, Wang X and Wang W: Targeted inhibition of focal
adhesion kinase attenuates cardiac fibrosis and preserves heart
function in adverse cardiac remodeling. Sci Rep. 7:431462017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao XK, Yu L, Cheng ML, Che P, Lu YY,
Zhang Q, Mu M, Li H, Zhu LL, Zhu JJ, et al: Focal adhesion kinase
regulates hepatic stellate cell activation and liver fibrosis. Sci
Rep. 7:40322017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan GP, Wang W, Zhao H, Cai L, Zhang PD,
Yang ZH, Zhang J and Wang X: Pharmacological inhibition of focal
adhesion kinase attenuates cardiac fibrosis in mice cardiac
fibroblast and post-myocardial-infarction models. Cell Physiol
Biochem. 37:515–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abedi H and Zachary I: Vascular
endothelial growth factor stimulates tyrosine phosphorylation and
recruitment to new focal adhesions of focal adhesion kinase and
paxillin in endothelial cells. J Biol Chem. 272:15442–15451. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wheaton AK, Agarwal M, Jia S and Kim KK:
Lung epithelial cell focal adhesion kinase signaling inhibits lung
injury and fibrosis. Am J Physiol Lung Cell Mol Physiol.
312:L722–L730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang HR, Lee CG, Homer RJ and Elias JA:
Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary
fibrosis. J Exp Med. 204:1083–1093. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan KT, Bennin DA and Huttenlocher A:
Regulation of adhesion dynamics by calpain-mediated proteolysis of
focal adhesion kinase (FAK). J Biol Chem. 285:11418–11426. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zitnik RJ, Kotloff RM, Latifpour J, Zheng
T, Whiting NL, Schwalb J and Elias JA: Retinoic acid inhibition of
IL-1-induced IL-6 production by human lung fibroblasts. J Immunol.
152:1419–1427. 1994.PubMed/NCBI
|
|
30
|
Zhou J, Sun X, Zhang J, Yang Y, Chen D and
Cao J: IL-34 regulates IL-6 and IL-8 production in human lung
fibroblasts via MAPK, PI3K-Akt, JAK and NF-κB signaling pathways.
Int Immunopharmacol. 61:119–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui Y, Robertson J, Maharaj S, Waldhauser
L, Niu J, Wang J, Farkas L, Kolb M and Gauldie J: Oxidative stress
contributes to the induction and persistence of TGF-β1 induced
pulmonary fibrosis. Int J Biochem Cell Biol. 43:1122–1133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang M, Cao SR, Zhang R, Jin JL and Zhu
YF: The inhibitory effect of salvianolic acid B on TGF-β1-induced
proliferation and differentiation in lung fibroblasts. Exp Lung
Res. 40:172–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khalil N, Xu YD, O'Connor R and Duronio V:
Proliferation of pulmonary interstitial fibroblasts is mediated by
transforming growth factor-beta1-induced release of extracellular
fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK.
J Biol Chem. 280:43000–43009. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Low RB, Cutroneo KR, Davis GS and Giancola
MS: Lavage type III procollagen N-terminal peptides in human
pulmonary fibrosis and sarcoidosis. Lab Invest. 48:755–759.
1983.PubMed/NCBI
|
|
35
|
Yurovsky V: TRAIL-mediated enhancement of
collagen production by human lung fibroblasts. Arthritis Res. 4
(Spuul 1):542002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Povedano JM, Martinez P, Serrano R, Tejera
Á, Gómez-López G, Bobadilla M, Flores JM, Bosch F and Blasco MA:
Therapeutic effects of telomerase in mice with pulmonary fibrosis
induced by damage to the lungs and short telomeres. Elife. 7(pii):
e312992018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen C, Yang S, Zhang M, Zhang Z, Hong J,
Han D, Ma J, Zhang SB, Okunieff P and Zhang L: Triptolide mitigates
radiation-induced pulmonary fibrosis via inhibition of axis of
alveolar macrophages-NOXes-ROS-myofibroblasts. Cancer Biol Ther.
17:381–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tabata C, Tabata R and Nakano T: The
calpain inhibitor calpeptin prevents bleomycin-induced pulmonary
fibrosis in mice. Clin Exp Immunol. 162:560–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Giménez A, Duch P, Puig M, Gabasa M,
Xaubet A and Alcaraz J: Dysregulated collagen homeostasis by matrix
stiffening and TGF-β1 in fibroblasts from idiopathic pulmonary
fibrosis patients: Role of FAK/Akt. Int J Mol Sci. 18(pii):
E24312017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li FZ, Cai PC, Song LJ, Zhou LL, Zhang Q,
Rao SS, Xia Y, Xiang F, Xin JB, Greer PA, et al: Crosstalk between
calpain activation and TGF-β1 augments collagen-I synthesis in
pulmonary fibrosis. Biochim Biophys Acta. 1852:1796–1804. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chan SL and Mattson MP: Caspase and
calpain substrates: Roles in synaptic plasticity and cell death. J
Neurosci Res. 58:167–190. 1999. View Article : Google Scholar : PubMed/NCBI
|
